Latest News
Moderna, Inc.
- Moderna Stock Plummets 18% After Cancer-Vaccine Data Leak
- Moderna, Merck shares fall on eagerly anticipated cancer vaccine results
- Detailed data confirm Moderna and Merck cancer vaccine met key endpoints in melanoma trial
- Moderna shares sink after leaked cancer data missed expectations
- Moderna, Merck Shares Fall After Possible Melanoma Data Leak
- Moderna’s Stock Plummets After Cancer-Vaccine Data Shared on Social Media
- Moderna shares plunge after cancer vaccine data leaks — despite positive results
- Moderna Stock Plunges 25% After Possible Cancer Vaccine Data Leak
- Moderna to replace Warner Bros Discovery on Nasdaq 100
- Moderna hits back against BioNTech and Pfizer in Hamburg
- Moderna | mRNA Vaccines, Cancer Therapies, & History
- Moderna Soars On Cancer Vaccine. Is mRNA Ready For Prime Time?
Headlines from the last 30 days, linking to the original publishers. See all market news →